China NMPA Answers Questions about CSAR Implementation

On Jan. 14, 2021, China National Medical Products Administration (NMPA) held a news briefing on Cosmetic Supervision and Administration Regulation (CSAR) implementation. ^[1] During the briefing, the following three officials answered several questions about CSAR implementation.

• Liubin Qi, Deputy Director of the Department of Cosmetics Regulation of NMPA;

• Qingbin Lin, Researcher of the Division of Supervision I; and

• Yunfeng Li, Division Chief of the Division of Supervision II.

Source: NMPA Official Website

ChemLinked summarizes the key points as follows.

1. No Pre-market Technical Review on Notification Documents